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Abstract 
Background: The ambulatory arterial stiffness index (AASI) is an indirect measure of arterial stiffness obtained during 
ambulatory blood pressuring monitoring (ABPM). Its relationship to nocturnal blood pressure dipping status and 
major adverse cardiovascular events (MACE) are controversial and its association with vascular inflammation has not 
been examined. We aimed to investigate the relationship between the AASI, inflammation and nocturnal blood pres‑
sure dipping status and its association with MACE.
Methods: Adults (aged 18–80 years) who underwent 24‑h ABPM for the diagnosis of hypertension or its control were 
included. The inflammatory markers measured were the neutrophil–lymphocyte (NLR), platelet‑lymphocyte (PLR) and 
monocyte‑lymphocyte ratios (MLR). The primary MACE was a composite of cardiovascular death, acute limb ischae‑
mia, stroke or transient ischaemic attack (TIA) or acute coronary syndrome.
Results: A total of 508 patients (51.2% female) aged 58.8 ± 14.0 years were included; 237 (46.7%) were normal‑dip‑
pers (≥ 10% nocturnal systolic dip), 214 (42.1%) were non‑dippers (0–10% dip) and 57 (11.2%) were reverse‑dippers 
(< 0% dip). The AASI was significantly higher among reverse (0.56 ± 0.16) and non‑dippers (0.48 ± 0.17) compared 
with normal dippers (0.39 ± 0.16; p < 0.0001) and correlated with the NLR (r = 0.20; 95% CI 0.11 to 0.29: < 0.0001) 
and systolic blood pressure dipping % (r = − 0.34; − 0.42 to − 0.26: p < 0.0001). Overall 39 (7.7%) patients had ≥ 1 
MACE which included a total of seven cardiovascular deaths and 14 non‑fatal strokes/TIAs. The mean follow up was 
113.7 ± 64.0 weeks. Increasing NLR, but not AASI or systolic dipping, was independently linked to MACE (overall 
model Chi‑square 60.67; p < 0.0001) and MLR to cardiovascular death or non‑fatal stroke/TIA (overall model Chi‑square 
37.08; p < 0.0001).
Conclusions: In conclusion AASI was associated with blood pressure dipping and chronic inflammation but not 
independently to MACE. The MLR and NLR were independent predictors of MACE.
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Introduction
Twenty four hour ambulatory blood pressure (ABP) 
monitoring (ABPM) represents the gold standard for the 
diagnosis of hypertension and assessment of its control 
[1–3]. Among the routinely reported ABPM variables 
the ambulatory arterial stiffness index (AASI) and blood 
pressure dipping status have gained increasing research 
interest. Non-dipping of nocturnal blood pressure has 
been independently linked to target organ damage and 
major adverse cardiovascular events (MACE) including 
stroke, cardiovascular death [4–6]. The AASI is consid-
ered an indirect measure of arterial stiffness. It strongly 
correlates with both pulse wave velocity and the arterial 
augmentation index and appears to be a complimentary 
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cardiovascular risk marker to conventional blood pres-
sure indices [7, 8].
Lower nocturnal blood pressure dipping is thought to 
reflect increased arterial stiffness. Less compliant and 
‘stiffer arteries’ are less distensible leading to lower rela-
tive nocturnal blood pressure and pulse pressure drop 
[9]. It would be expected that as a surrogate of arterial 
stiffness AASI would be linked to blood pressure dipping 
status, vascular inflammation and adverse cardiovascular 
events. However, there have been few studies that have 
examined the relationship between AASI and blood pres-
sure dipping [10–12] and none to investigate its links to 
inflammation. Whilst increasing AASI has been linked 
to adverse cardiovascular outcomes and worsening renal 
function these links and its relative benefits over tradi-
tional ABPM measures remain controversial [8, 13, 14].
Vascular inflammation is an established risk marker 
and key pathogenic mediator in the development of 
endothelial dysfunction, atherosclerosis and subse-
quently increasing arterial stiffness [15]. Stimulated white 
blood cells (WBC) can adhere and penetrate the vascu-
lar endothelial intima leading to capillary leukostasis, 
vascular damage and an increase in arterial stiffness [16, 
17]. Several differential WBC ratios have evolved as use-
ful markers of chronic vascular inflammation and been 
linked to measures of arterial stiffness and major adverse 
cardiovascular events (MACE) [18–20]. Among the dif-
ferential white cell indices the greatest evidence exists for 
the neutrophil–lymphocyte (NLR), platelet-lymphocyte 
(PLR) and monocyte-lymphocyte ratios (MLR). These 
measurements have the advantage over many other 
established inflammatory markers owing to their high 
reproducibility, low cost determination, widespread 
availability and ease of measurement. The relationship of 
AASI and inflammation, to blood pressure dipping status 
and cardiovascular outcomes have not been examined.
This study had two discrete aims. The first was to inves-
tigate the relationship between AASI, vascular inflam-
mation (using lymphocyte ratios) and nocturnal blood 
pressure dipping status. The second was to examine their 
association with future MACE. We hypothesised that 
AASI would be significantly associated with blood lym-




This study followed the STROBE Initiative Guidelines for 
cohort studies [21]. This was a single centre retrospective 
observational study. Consecutive adults aged 18–80 years 
who underwent 24-h ABPM for the diagnosis of hyper-
tension, or its control, at our institution were included.
Key exclusion criteria were patients with previous 
organ transplantation, persistent/ permanent atrial fibril-
lation, a calculated creatinine clearance of < 30 ml/min 
or known stage IV or V chronic kidney disease (CKD), 
pregnancy or with active cancer. Patients with severe aor-
tic stenosis, aortic coarctation, active infection or vascu-
litis, on high dose steroids or who had been hospitalised 
within the previous week were also excluded.
24 Hour ambulatory blood pressure measurement
All tests were performed using an automatic ABPM 
device (Spacelab 90207, Spacelab Healthcare, Hertford, 
UK). An automated oscillometric cuff was placed on 
the non-dominant arm. Blood pressure measurements 
were set to minute intervals throughout a 24-h recording 
period. The night-time period was defined as the hours 
of 22:01 to 06:00 h and the day-time period as 06:01 to 
22:00 h. Patients were only included if they had a mini-
mum of 10 day-time and 5 night-time ambulatory blood 
pressure measures during the 24  h recording period [6, 
22]. Patients were advised not to have their ABPM during 
periods of night shift work.
Nocturnal dipping status was classified into three 
groups based on the percentage change in mean night 
time to day time blood pressure as previously defined (a) 
normal dippers (≥ 10%); (b) non‐dipper (≥ 0% but < 10%) 
and (c) reverse dipper (< 0%) [6, 23].The AASI was cal-
culated, as previously defined, as 1 minus the regression 
slope of the diastolic to systolic blood pressure over the 
24 h recording period [24]. Increasing AASI values indi-
cate stiffer arteries with all values ranging between 0 and 
1.0.
The Primary Endpoint was a composite MACE of car-
diovascular death, non-fatal acute limb ischaemia, stroke 
or transient ischaemic attack (TIA) or acute coronary 
syndrome (ACS) [25]. Our secondary outcome of interest 
was cardiovascular death or non-fatal stroke. ACS was 
defined in accordance with the European Society of Car-
diology Guidelines and required diagnostic confirmation 
by a cardiologist. The diagnosis of stroke or TIA were 
based on clinical presentation, supported by radiological 
imaging and had to be confirmed by a stroke physician. 
Acute limb ischaemia was defined as a sudden decrease 
in limb perfusion causing a potential threat to limb viabil-
ity and requiring hospitalisation. Coronary artery disease 
(CAD) was defined as a previous myocardial infarction, 
percutaneous coronary angioplasty/stenting, or a signifi-
cant stenosis of ≥ 70% in ≥ 1 major coronary arteries [26].
Blood tests
Venous blood for the measurement of lipid profile, full 
blood count, renal function and Glycated haemoglobin 
(HbA1c) were analysed in our hospital laboratory and 
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examined within three months of ABPM. The creati-
nine clearance was calculated using the Cockcroft-Gault 
Equation [27].
Ethical approval
This study and its experimental protocol were approved 
by the Poole Hospital Clinical Research and Innovation 
Department and the West of Scotland Research Ethics 
Committee (REC reference: 20/WS/0097). As this was a 
registry study the need for written informed consent was 
deemed not to be necessary by the ethics committee.
Statistical analysis
Statistical analyses were performed with the SPSS 26.0 
(SPSS, Chicago, IL, USA) and GraphPad Prism version 
6.07 for Windows (GraphPad Software, San Diego, CA, 
USA). Data inspection and the D’Agostino–Pearson nor-
mality were used to assess normality of all continuous 
data. Continuous data were presented as mean ± stand-
ard deviations except for highly skewed data where the 
median [interquartile range] were shown. Comparisons 
of continuous data among two groups were performed 
using an unpaired t test and Mann–Whitney test for 
normal and non-normally distributed data respectively. 
Three group comparisons of continuous data (normal, 
non- and reverse-systolic blood pressure dippers) were 
performed using a One-way ANOVA and Kruskal–Wallis 
tests with post-tests for normally and non-normally dis-
tributed data respectively. Categorical data were exam-
ined using the Fisher’s exact tests and chi squared tests as 
appropriate. Correlations were investigated using Pear-
son and Spearman rank coefficients (± 95% confidence 
interval [CI]) as appropriate. Only notable correlations 
with a coefficient r ≥ 0.20 were reported.
Associations between prognostic variables and MACE 
were examined by univariate and multivariate Cox pro-
portional hazards analysis with the results reported as the 
odds ratio (B) and 95% confidence intervals (CI), respec-
tively. Only variables with a p value < 0.05 on univariate 
testing or that were considered clinically relevant with 
outcomes were entered into the multivariate analyses. To 
avoid over-fitting a forward LR (likelihood ratio) method 
were performed with retention set at a significance level 
of 0.10. Sensitivity analyses were performed to assess 
the robustness of the final model. A two-sided p value 
of < 0.05 was considered significant for all comparisons.
Sample size calculations
This was performed using a proprietary sample-size 
calculator (GraphPad StatMate version 2.00 for Win-
dows). Published data has suggested an average stand-
ard deviation for the AASI of 0.06 to 0.22 among adults 
with and without hypertension or cardiovascular disease 
[8]. Based on this data we estimated that a sample size 
of at least 150 patients per group with and without sys-
tolic blood pressure dipping would have > 80% power to 
detect a difference between mean AASI values of ≥ 0.05 
with a significance level (alpha) of 0.05 (two-tailed). This 
group sample size among non-normal versus normal dip-




A total of 508 patients were included in this study of 
which 260 (51.2%) were women. The mean age was 
58.8 ± 14.0 (range 18–80) years. Overall 98.6% of the pop-
ulation were Caucasian; 66.34% had a previous history of 
hypertension, 16.9% diabetes mellitus and 8.7% had suf-
fered a previous stroke or TIA. The men (58.4 ± 13.95) 
and women (59.2 ± 14.1) were of similar age (p = 0.55).
Dipping status and cardiovascular risk factors
From the total cohort 237 (46.7%) patients were classed 
as normal-dippers, 214 (42.1%) non-dippers and 57 
(11.2%) reverse-dippers (Table  1). The reverse-dippers 
and were older and more likely to have a history of heart 
failure, peripheral vascular disease (PVD) and diabetes 
mellitus compared with normal and non-dippers. Cre-
atinine clearance and high-density lipoprotein (HDL) 
concentrations were significantly lower and NLR and 
HBA1c levels higher amongst the reverse dippers versus 
the normal and non-dippers (Table  1). Conversely, the 
NLR, MLR and HBA1c levels were progressively higher 
among the non-dippers and reverse-dippers respectively 
(Table 1). MACE events were more common among the 
reverse-dippers.
Non-dippers and reverse-dippers had significantly 
higher 24  h average systolic blood pressure and pulse 
pressure than normal-dippers. Non and reverse-dippers 
had higher AASI (Fig.  1), night-time systolic, diastolic, 
mean arterial blood pressure and pulse pressures com-
pared with the normal dippers respectively (Table  2). 
Day-time diastolic blood pressure and mean arterial 
blood pressures were higher yet pulse pressure lower 
in normal-dippers versus non- and reverse-dippers 
respectively.
Relationship between AASI to inflammation, dipping 
status and other variables
AASI positively correlated with age (r = 0.48; 0.41 to 0.54; 
p < 0.0001), HBA1c (r = 0.30; 0.21 to 0.39: p < 0.0001), 
NLR (r = 0.20; 0.11 to 0.29: < 0.0001) and systolic blood 
pressure (r = 0.26; 0.17 to 0.34: p < 0.0001). AASI inversely 
correlated with creatinine clearance (r = − 0.32; − 0.40 to 
− 0.23: p < 0.0001), diastolic blood pressure (r = − 0.23; 
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− 0.32 to − 0.15: p < 0.0001) systolic blood pressure dip-
ping % (r = − 0.34; − 0.42 to − 0.26: p < 0.0001), dias-
tolic blood pressure dipping % (r = − 0.48; − 0.55 to 
− 0.41: p < 0.0001) and MAP blood pressure dipping % 
(r = − 0.44; − 0.51 to − 0.36: p < 0.0001).
The AASI was significantly greater in women versus 
men (0.47 ± 0.17 vs. 0.43 ± 0.17; p = 0.02). AASI values 
were also higher in those with, versus without respec-
tively, a history of CAD (0.49 ± 0.16 vs. 0.44 ± 0.18; 
p = 0.003), diabetes mellitus (0.55 ± 0.15 vs. 0.43 ± 0.17; 
p < 0.0001), previous stroke/TIA (0.54 ± 0.19 vs. 
0.44 ± 0.19; p = 0.0008), PVD (0.52 ± 0.14 vs. 0.44 ± 0.17; 
p = 0.034), known hypertension (0.46 ± 0.17 vs. 
0.42 ± 0.17; p = 0.004).
Outcome data
Overall 39 (7.7%) patients had one or more adverse cardi-
ovascular events which included a total of seven cardio-
vascular deaths and 14 non-fatal strokes/TIAs. The mean 
follow up (to death or analysis) was 113.7 ± 64.0 weeks.
Table 1 Relationship between baseline demographics, cardiovascular risk factors and blood marker with blood pressure dipping 
status
TIA, transient ischaemic attack; HBA1c Glycosylated haemoglobin; HDL, high density lipoprotein
p values refer to the results of overall comparison between the three groups: 1. Normal dippers, 2. Non-dippers and 3. Reverse-dippers. Significant difference on post 
hoc tests a. normal vs. non dippers, b. normal vs. reverse dippers, c. non vs. reverse dippers
Characteristic Normal‑dippers Non‑dippers Reverse‑dippers p value
Number (% 237 (46.7%) 214 (42.1%) 57 (11.2%)
Age, years 56.3 ± 13.9 60.5 ± 13.3 62.6 ± 15.4 0.0006ab
Male sex (%) 120 (50.6%) 99 (46.3%) 29 (50.9%) 0.61
Height, cm 168.7 ± 10.9 168.5 ± 9.7 168.6 ± 11.7 0.98
Weight, kg 81.9 ± 18.0 82.4 ± 19.6 86.6 ± 24.0 0.27
Body mass index, kg/m2 28.8 ± 5.5 29.0 ± 6.1 30.3 ± 6.5 0.26
Coronary artery disease 43 (18.1%) 44 (20.6%) 15 (26.3%) 0.37
Heart failure 6 (2.5%) 9 (4.2%) 8 (14.0%) 0.0008
Peripheral vascular disease 9 (3.8%) 5 (2.3%) 11 (19.3%) < 0.0001
Diabetes mellitus 24 (10.1%) 43 (20.1%) 19 (33.3%) < 0.0001
Previous stroke /TIA 21 (8.8%) 11 (5.1%) 8 (14.0%) 0.06
Known hypertension 155 (65.4%) 143 (66.8%) 44 (77.2%) 0.23
Current/ex‑smokers 98 (41.4%) 96 (44.9%) 29 (50.9%) 0.40
Ejection fraction, % 59.8 ± 8.2 59.2 ± 9.6 57.5 ± 9.0 0.27
Haemoglobin g/l 141.3 ± 14.9 138.4 ± 15.0 136.5 ± 14.9 0.051
Neutrophil/lymphocyte ratio 2.1 [1.6–2.9] 2.3 [0.7–3.4] 2.6 [2.0–3.9] < 0.0001ab
Platelet/lymphocyte ratio 145.3 ± 75.8 154.7 ± 70.5 167.2 ± 92.2 0.11
Monocyte/lymphocyte ratio 0.32 ± 0.16 0.33 ± 0.17 0.37 ± 0.18 0.13
Creatinine clearance 76.8 ± 26.7 72.1 ± 28.1 70.5 ± 37.3 0.016b
Total cholesterol, mmol/l 4.9 ± 1.1 4.7 ± 1.2 4.6 ± 1.0 0.18
HDL cholesterol, mmol/l 1.56 ± 0.5 1.49 ± 0.5 1.38 ± 0.4 0.037b
Triglycerides, mmol/l 1.52 ± 0.9 1.57 ± 0.9 1.73 ± 1.0 0.17
HBA1c, mmol/mol 41.2 ± 12.1 43.9 ± 12.6 49.39 ± 21.3 0.0008bc
















Fig. 1 Relationship between AASI and systolic blood pressure 
dipping status (*refers to significance between groups)
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The univariate predictors of MACE were age, history 
of stroke/TIA, heart failure, coronary disease, hyperten-
sion and PVD, AASI, lower systolic blood pressure dip-
ping (%), mean arterial blood pressure dipping (%) and 
24 h pulse pressure, NLR, MLR, creatinine clearance, and 
lower haemoglobin (Table 3).
The only independent predictors of MACE were 
increasing age, a history of heart failure, PVD, previ-
ous stroke/TIA, lower haemoglobin and increasing NLR 
(overall model Chi-square 60.67; p < 0.0001) (Table  3). 
Previous stroke/TIA, MLR (OR 1.04; 1.02–1.06: 
p = 0.009), PVD and female sex were independent predic-
tors of future cardiovascular death or non-fatal stroke/
Table 2 Relationship of ambulatory blood pressure parameters to systolic blood pressure dipping status
ABPM Ambulatory blood pressure monitoring; AASI, Ambulatory arterial stiffness index
p values refer to the results of overall comparison between the three groups: 1. normal dippers, 2. non-dippers and 3. reverse dippers. Significant difference on post 
hoc tests: a. Normal vs. non-dippers, b. Normal vs. reverse-dippers, c. Non vs. reverse-dippers
Characteristic Normal dippers Non dippers Reverse dippers p value
24 h ABPM averages
Systolic blood pressure, mmHg 129.6 ± 14.1 133.9 ± 15.6 135.4 ± 15.9 0.002ab
Diastolic blood pressure, mmHg 77.0 ± 9.7 76.1 ± 10.6 74.3 ± 11.7 0.18
Mean arterial blood pressure, mmHg 95.1 ± 9.8 96.3 ± 10.5 95.8 ± 11.8 0.49
Pulse pressure, mmHg 52.6 ± 11.8 57.8 ± 13.3 61.2 ± 10.9 < 0.0001ab
Day-time averages
Systolic blood pressure, mmHg 135.4 ± 14.9 135.9 ± 15.7 134.0 ± 15.9 0.71
Diastolic blood pressure, mmHg 81.3 ± 10.3 77.9 ± 10.6 74.2 ± 11.8 < 0.0001ab
Mean arterial pressure, mmHg 99.9 ± 10.4 98.1 ± 10.5 95.3 ± 12.0 0.008b
Pulse pressure, mmHg 54.1 ± 12.60 57.9 ± 13.5 59.8 ± 10.7 0.0009ab
Night-time averages
Systolic blood pressure, mmHg 114.2 ± 12.0 128.1 ± 15.2 139.9 ± 16.3 < 0.0001abc
Diastolic blood pressure, mmHg 65.6 ± 8.6 70.3 ± 9.7 74.7 ± 11.4 < 0.0001abc
Mean arterial pressure, mmHg 82.7 ± 8.8 90.9 ± 10.3 97.6 ± 11.6 < 0.0001abc
Pulse pressure, mmHg 48.7 ± 10.7 57.8 ± 12.8 65.2 ± 12.7 < 0.0001abc
Systolic blood pressure dip, % 14.2 [12.2–18.4] 6.0 [3.2 to 8.3] − 3.8 [− 6.6 to − .2] < 0.0001abc
AASI 0.39 ± 0.16 0.48 ± 0.17 0.56 ± 0.16 < 0.0001abc
Table 3 Results of univariate and multivariate Cox regression analysis for MACE
TIA, transient ischaemic attack; HBA1c Glycosylated haemoglobin; AASI, ambulatory arterial stiffness index; NS, non-significant
Characteristic Univariate analysis Multivariate analysis
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Age, years 1.07 (1.03–1.10) < 0.0001 1.04 (1.001–1.08) 0.044
Male sex (%) 0.73 (0.38–1.37) 0.33 – NS
Coronary artery disease 2.333 (1.20–4.50) 0.013 – NS
Heart failure 5.62 (2.47–12.81) < 0.0001 5.65 (2.36–13.55) < 0.0001
Diabetes mellitus 2.50 (1.25–4.90) 0.010 – NS
Previous stroke /TIA 3.20 (1.40–7.30) 0.006 2.49 (1.05–5.93) 0.039
Known hypertension 3.26 (1.27–8.34) 0.014 – NS
Peripheral vascular disease 4.61 (2.02–10.51) < 0.0001 3.0 (1.27–7.10) 0.013
Haemoglobin 0.97 (0.95–0.98) 0.002 0.98 (0.96–0.99) 0.045
Neutrophil/lymphocyte ratio 1.17 (1.08–1.28) < 0.0001 1.13 (1.02–1.24 0.02
Monocyte/lymphocyte ratio 1.02 (1.01–1.04) < 0.0001 – NS
Creatinine clearance 0.98 (0.97–0.99) 0.01 – NS
Systolic blood pressure dip, % 0.95 (0.91–0.98) 0.012 – NS
AASI 1.03 (1.01–1.05) 0.006 – NS
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TIA (overall model Chi-square 37.08; p < 0.0001). The full 
database is available in the supplement (Additional file 1).
Discussion
This was first study to investigate the relationship 
between AASI, vascular inflammation and blood pres-
sure dipping and their association to adverse cardiovas-
cular outcomes. We found that a reduced blood pressure 
dipping pattern was linked to higher AASI and measures 
of vascular inflammation (MLR and NLR). Systolic blood 
pressure dipping %, AASI, MLR and NLR were associated 
with MACE on univariate analyses. Increased NLRs were 
independently associated with MACE and MLR with car-
diovascular death or non-fatal stroke/TIA.
To our knowledge this is the largest and one of the few 
studies to investigate the relationship between systolic 
blood pressure dipping and vascular inflammation using 
lymphocyte ratios. We observed an inverse relation-
ship between the neutrophil and monocyte-lymphocyte 
ratios and systolic blood pressure dipping. Higher ratios 
were associated with non- and reverse blood pressure 
dipping, which are recognised risk markers of increased 
cardiovascular risk [5]. Previously, Sabul et  al. (n = 166) 
observed higher NLR in patients among non-dipper 
versus with dipper adult hypertensives respectively. In 
another study, Ahbap et al. observed higher NLR among 
dipper versus non dipper hypertensives with CKD sup-
porting our results. The MLR is rapidly emerging as 
another important marker of vascular inflammation 
has been linked to carotid stenosis severity in ischaemic 
stroke and to the severity of coronary disease and car-
diovascular mortality [28–30]. There was no association 
between PLR and either blood pressure dipping status or 
MACE in our cohort.
Chronic vascular inflammation and the infiltration of 
the vascular endothelium with leukocyte subsets is one 
of the primary driving forces in the development of ath-
erosclerotic cardiovascular disease [31]. Lipid accumula-
tion within the vascular wall intima leads to passage of 
stimulated monocytes, which are major precursors of 
macrophage, passage across the endothelium [31]. Neu-
trophils and platelets also influence atherosclerosis and 
its complications by intensifying inflammation with 
platelets also contributing to clot formation. We found 
that the NLR was an independent predictor of our pri-
mary MACE and the MLR independently predicted 
cardiovascular mortality as well as the composite of car-
diovascular mortality and non-fatal stroke or TIA. These 
results add further weight to the current evidence sup-
porting the potential utility of lymphocyte biomarkers 
in cardiovascular risk assessment. They have the advan-
tage over many traditional markers due to their low cost, 
widespread use and the rapid availability of results.
Our interest in the AASI stems from its easy computa-
tional availability with automated results included in our 
standardised reports, coupled most importantly with its 
cited role as a potential indirect marker of arterial stiff-
ness. All of the factors that we found to be associated 
with AASI and its higher levels in this study are recog-
nised risk factors for increased arterial stiffness, with one 
exception. We observed that women had significantly 
higher AASI values than men despite their similar ages. 
This could relate, in part, to differences in their comor-
bidities and relative burden of cardiovascular risk factors 
(eg hypertension, lipid profiles etc.). A detailed compar-
ison was beyond the scope of this study. It is neverthe-
less notable that it has been reported that women exhibit 
greater age related increase in measures of large artery 
stiffness than men, supporting our findings [32–34].
The relationship between AASI and systolic blood pres-
sure dipping status has only been previous examined in 
a few studies with conflicting results [10, 12]. We found 
that AASI values were progressively and significantly 
higher in non-dippers and reverse dippers versus normal 
dippers. Moreover, dipping status was an independent 
predictor of AASI and likely increased arterial stiffness.
This study has a number of limitations that should be 
acknowledged. This was a retrospective single centre 
study and hence prone to potential bias. Only outcomes 
registered with the local hospitals could be monitored 
and hence we cannot exclude the possibility that some 
patients could have presented to another hospital with 
a cardiovascular event outside of our locality. However, 
these numbers are likely to be very small given that only 
local and registered patients were included and there 
were on-going active records available for the vast major-
ity of patients. All 24-h ABPM were set to similar times 
for the determination or day-time and night-time blood 
pressures and its associated indices. Given the wide 
range of ages of patients included in this study it is likely 
that there would have been periods graded as effectively 
night-time when the patients were still very much awake 
and day-time when patients may have been asleep. The 
use of a wide fixed night-time period in this study could 
have led to inclusion of transition periods in the morning 
and evening when blood pressure changes rapidly leading 
to the potential misclassification of dipping status [35]. 
However, at present there is a lack of consensus on the 
optimal nocturnal recording period to determine dipping 
status [2, 3, 23]. Furthermore, the links between non/
reverse dipping status and MACE have been observed 
with various classifications including wide fixed night-
time periods as in this study [6, 36]. Finally whilst our 
sample size was reasonable our event rates were relatively 
low and hence, despite conducting sensitivity testing, we 
cannot exclude the potential for bias.
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In conclusion, in this study we found that that AASI 
was significantly correlated with NLR and inversely 
related to systolic blood pressure dipping. Systolic blood 
pressure dipping, AASI, the neutrophil and monocyte-
lymphocyte ratios were univariate predictors of MACE. 
The NLR was an independent predictor of the primary 
MACE, and MLR for cardiovascular death or non-fatal 
stroke. This data endorses the association between AASI, 
inflammation and cardiovascular risk.
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